Welcome to Prostate Cancer and Prostatic Diseases

Prostate Cancer and Prostatic Diseases, covering all aspects of prostatic diseases, in particular prostate cancer. The journal is of interest to surgeons, oncologists, clinicians, and researchers involved in disease of the prostate. The journal publishes original research articles, reviews, topical comments, and critical appraisal of scientific meetings.

Free online issue

Volume 12, No 4
December 2009

ISSN: 1365-7852
EISSN: 1476-5608

Impact Factor 2.062*
27/57 Urology & Nephrology
99/141 Oncology

Editors:
Roger S Kirby
Judd W Moul

*2008 Journal Citation Report (Thomson Reuters, 2009)

NEWS

Impoving blood loss preparation. Age and preoperative PSA may not indicate a patients estimated blood loss (EBL) during radical prostatectomy. Read how high BMI and large prostate size could better indicate individual blood loss during surgery.

Gene therapy for prostate cancer. Prostate cancer affects one in six men and is the second leading cause of cancer death among men in the US. Gene therapy shows promise as a treatment strategy that can target both localized and metastatic prostate cancer. View this web focus to read more about the field of prostate cancer gene therapy.

Nature Publishing Group and AstraZeneca are pleased to congratulate the 2008 AstraZeneca Scholarship award recipients, Young et al., for their winning paper entitled "Combining gene and immunotherapy for prostate cancer". The award is bestowed on the most significant original research paper published in 2008.

Extra navigation

21 November 2009

naturejobs

ADVERTISEMENT